Vir Biotechnology opens new office in St. Louis - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 68%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

A San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis.

, Vir’s senior vice president of microbiology and virology and St. Louis site head, said the company’s new local office will focus on research and development, supporting pre-clinical testing to advance and commercialize its drug pipeline. Purcell said St. Louis' new office gives it proximity to research institutions and collaborators like Saint Louis University and Washington University and places it within a “thriving bioscience community.”Vir announced its St.

Scroll through the gallery above to take a look inside Vir's new office in the Cortex innovation district. Vir tapped HOK as architect for its new St. Louis office, with Tarlton Corp. acting as general contractor. Several local economic development groups said they were involved in securing Vir’s St. Louis expansion, including Greater St. Louis Inc., Missouri Partnership, Missouri Department of Economic Development, St. Louis Economic Development Partnership and St. Louis Development Corporation. As part of its expansion, Vir is eligible to receive state incentives though Missouri Works Program, which helps businesses access capital through withholdings or tax credits.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 78. in RU

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Vir Biotechnology opens new office in St. Louis - San Francisco Business TimesThe San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis, opening a new $41 million office within the Cortex innovation district. It says the new facility will be critical to advancing research to treat several infectious diseases, including Covid-19.
Источник: SFBusinessTimes - 🏆 78. / 68 Прочитайте больше »